Relative HRs of colorectal cancer for the gout and control groups
| Colorectal cancer | Adjusted HR (95% CI)* | ||||
| No | Yes | ||||
| n | % | n | % | ||
| Gout | |||||
| No | 82 568 | 98.00 | 1680 | 2.00 | 1.00 |
| Yes | 27 488 | 97.96 | 573 | 2.04 | 1.04 (0.95 to 1.15) |
| Age, years | |||||
| <30 | 12 479 | 99.75 | 31 | 0.25 | 1.00 |
| 30–44 | 28 310 | 99.33 | 190 | 0.67 | 2.63 (1.8 to 3.86) |
| 45–59 | 31 851 | 98.20 | 584 | 1.80 | 7.39 (5.03 to 10.87) |
| ≥60 | 37 416 | 96.27 | 1448 | 3.73 | 17.13 (11.09 to 26.46) |
| Sex | |||||
| Male | 87 367 | 98.06 | 1732 | 1.94 | 1.43 (1.30 to 1.59) |
| Female | 22 689 | 97.76 | 521 | 2.24 | 1.00 |
| Geographic area | |||||
| Northern | 51 349 | 97.77 | 1171 | 2.23 | 1.73 (1.27 to 2.35) |
| Central | 26 065 | 98.22 | 472 | 1.78 | 1.23 (0.91 to 1.65) |
| Southern | 29 476 | 98.14 | 558 | 1.86 | 1.32 (0.97 to 1.78) |
| Eastern | 3166 | 98.38 | 52 | 1.62 | 1.00 |
| Urbanisation status | |||||
| Urban area | 46 303 | 98.00 | 945 | 2.00 | 0.95 (0.82 to 1.10) |
| Satellite area | 31 427 | 98.03 | 631 | 1.97 | 0.92 (0.80 to 1.05) |
| Rural area | 32 317 | 97.95 | 677 | 2.05 | 1.00 |
| Comorbidity | |||||
| Hypertension | 32 920 | 96.99 | 1022 | 3.01 | 1.07 (0.66 to 1.72) |
| Diabetes | 16 190 | 97.12 | 480 | 2.88 | 1.04 (0.92 to 1.17) |
| Hyperlipidaemia | 21 600 | 97.35 | 587 | 2.65 | 0.97 (0.61 to 1.54) |
| CCI | 1.06 (1.01 to 1.11) | ||||
| PS | 1.79 (0.13 to 24.11) | ||||
*Adjusted model, adjusted for age, sex, urbanisation, hypertension, diabetes, hyperlipidaemia, CCI and PS.
CCI, Charlson comorbidity index; PS, propensity score.